DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 68 filers reported holding DENALI THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122,969,901 | -31.8% | 5,960,732 | -2.5% | 14.32% | -23.9% |
| Q2 2023 | $180,327,701 | +22.1% | 6,110,732 | -4.7% | 18.83% | +7.4% |
| Q1 2023 | $147,703,265 | -22.6% | 6,410,732 | -6.6% | 17.54% | -37.3% |
| Q4 2022 | $190,796,957 | -13.2% | 6,860,732 | -4.2% | 27.96% | -5.9% |
| Q3 2022 | $219,763,000 | +0.1% | 7,160,732 | -4.0% | 29.71% | +3.7% |
| Q2 2022 | $219,569,000 | -8.5% | 7,460,732 | 0.0% | 28.65% | -0.4% |
| Q1 2022 | $240,012,000 | -30.2% | 7,460,732 | -3.2% | 28.78% | +12.1% |
| Q4 2021 | $343,645,000 | -11.6% | 7,705,039 | 0.0% | 25.68% | -29.8% |
| Q3 2021 | $388,719,000 | -39.1% | 7,705,039 | -5.3% | 36.56% | -33.6% |
| Q2 2021 | $638,147,000 | +11.9% | 8,135,481 | -18.5% | 55.02% | -24.0% |
| Q1 2021 | $570,134,000 | +68.2% | 9,984,836 | -48.7% | 72.40% | +101.4% |
| Q4 2020 | $339,037,000 | -22.4% | 19,462,500 | +59.5% | 35.95% | -44.2% |
| Q3 2020 | $437,185,000 | +32.5% | 12,201,634 | -10.6% | 64.45% | +6.6% |
| Q2 2020 | $329,933,000 | -39.5% | 13,644,881 | -56.2% | 60.47% | -22.9% |
| Q1 2020 | $545,182,000 | +60.8% | 31,135,472 | +60.0% | 78.45% | +78.7% |
| Q4 2019 | $339,037,000 | +13.7% | 19,462,500 | 0.0% | 43.90% | -8.6% |
| Q3 2019 | $298,165,000 | -26.2% | 19,462,500 | 0.0% | 48.02% | -11.7% |
| Q2 2019 | $404,042,000 | -10.6% | 19,462,500 | 0.0% | 54.41% | -44.5% |
| Q1 2019 | $451,919,000 | +12.4% | 19,462,500 | 0.0% | 98.01% | +61.2% |
| Q4 2018 | $402,095,000 | -10.1% | 19,462,500 | -5.4% | 60.80% | +46.8% |
| Q3 2018 | $447,285,000 | +42.6% | 20,574,299 | 0.0% | 41.41% | +25.6% |
| Q2 2018 | $313,758,000 | -22.5% | 20,574,299 | 0.0% | 32.97% | -34.6% |
| Q1 2018 | $405,107,000 | +25.9% | 20,574,299 | +0.0% | 50.40% | +52.9% |
| Q4 2017 | $321,782,000 | – | 20,574,298 | – | 32.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |